Consensus Abbott Laboratories Deutsche Boerse AG

Stocks

ABL0

CA0028221046

Medical Equipment, Supplies & Distribution

Market Closed - Deutsche Boerse AG 09:45:03 2026-10-30 EDT			5-day change	1st Jan Change
11.80 ^EUR	+3.51%		+4.42%	-11.94%

10-29	Perrigo to sell infant formula business to MeridianMade for up to $175 million	RE
10-29	Perrigo to sell infant formula business to MeridianMade for up to $175 million	RE

cbd502ca9f9993b4008a11.VW-kZ6NWsoF5Y4fKMRc_RsMqLgukczx8KgOfte0-BJM.HhfqIcEM9NNAWvGACX1zEo1pRnLJKmYpQXfSgJddb6AbX-8gkgPK7Ssa3g~13985ce074e62de677bb17e224f7dac6

Analysts' recommendations: Abbott Laboratories

10-27	Abbott Laboratories Shares Fall After Argus Downgrade	MT
10-27	Argus Downgrades Abbott Laboratories to Hold From Buy	MT
10-22	Abbott Laboratories' 2026 Guidance Cut Driven by Diabetes, Electrophysiology Portfolio, RBC Says	MT
10-22	Jefferies & Co Adjusts Abbott Laboratories Price Target to $130 From $135	MT
10-22	RBC Trims Price Target on Abbott Laboratories to $125 From $130, Keeps Outperform Rating	MT
10-22	Leerink Partners Adjusts Price Target on Abbott Laboratories to $106 From $109	MT
10-22	BTIG Adjusts Price Target on Abbott Laboratories to $125 From $134	MT
10-22	Wells Fargo Adjusts Price Target on Abbott Laboratories to $119 From $112	MT
10-22	JPMorgan Adjusts Price Target on Abbott Laboratories to $118 From $120	MT
10-22	TD Cowen Adjusts Price Target on Abbott Laboratories to $118 From $135	MT
10-20	Abbott Laboratories' Established Pharma Unit Undervalued on Biosimilars Potential, UBS Says	MT
10-07	Barclays Initiates Coverage on Abbott Laboratories With Overweight Rating, $120 Price Target	MT
10-05	Evercore ISI Adjusts Price Target on Abbott Laboratories to $124 From $120, Keeps Outperform Rating	MT
10-02	Rothschild & Co Redburn Upgrades Abbott Laboratories to Buy From Neutral, Adjusts PT to $127 From $119	MT
10-02	Rothschild & Co Redburn Upgrades Abbott Laboratories to Buy From Neutral, Adjusts PT to $127 From $119	MT
10-02	Analyst recommendations: Airbnb, Hewlett Packard Enterprise, Fair Isaac, Nike…
08-21	TD Cowen Adjusts Price Target on Abbott Laboratories to $135 From $115, Maintains Buy Rating	MT
08-13	Citigroup Adjusts Price Target on Abbott Laboratories to $125 From $112, Maintains Buy Rating	MT
08-13	Wolfe Research Upgrades Abbott Laboratories to Outperform From Peer Perform, PT is $130	MT
07-28	UBS Adjusts Price Target on Abbott Laboratories to $125 From $135, Maintains Buy Rating	MT
07-28	Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating	MT
07-23	Daiwa Securities Adjusts Price Target on Abbott Laboratories to $103 From $92, Maintains Neutral Rating	MT
07-22	Leerink Partners Adjusts Price Target on Abbott Laboratories to $109 From $106, Maintains Market Perform Rating	MT
07-17	Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says	MT
07-17	JPMorgan Adjusts Price Target on Abbott Laboratories to $120 From $110, Maintains Overweight Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ABBOTT LABORATORIES					+11.6%
	STRYKER CORPORATION					+20.07%
	MEDTRONIC PLC					+8.36%
	ESSILORLUXOTTICA					+17.15%
	CENCORA, INC.					+12.34%
	HOYA CORPORATION					+16.9%
	BECTON, DICKINSON AND COMPANY					-1.17%
	IDEXX LABORATORIES, INC.					+25.98%
	ALCON INC.					+25.55%
	Average					+15.20%
	Weighted average by Cap.					+14.04%